Originally posted by cmccabe
View Post
Unconfigured Ad
Collapse
X
-
Here are the steps:
after that I renamed the folder to bowtie2-2.2.6 and added that to path using:Code:wget https://github.com/BenLangmead/bowtie2/archive/master.zip unzip master.zip cd /home/dnascopev/Desktop/master make
Thank youCode:echo 'export PATH=$PATH:/home/dnascopev/Desktop/bowtie2-2.6.0' >> ~/.bashrc
.
Comment
-
the build indexs is running:
Are these normal?
Code:Warning: Encountered empty reference sequence Warning: Encountered reference sequence with only gaps Warning: Encountered reference sequence with only gaps Warning: Encountered empty reference sequence Warning: Encountered empty reference sequence Warning: Encountered reference sequence with only gaps Warning: Encountered empty reference sequence
was used to build the indexCode:bowtie2-build -f /home/dnascopev/Desktop/hg19_fasta/hg19.fa /home/dnascopev/Desktop/hg19_fasta/my_hg19
was used to concatenate the fa from chromFa.tar.gzCode:cat *.fa > hg19.fa
Thank you
.
Comment
-
bowtie2-build: command not found
I downloaded the bowtie 2-2.3.5.1 for mac using the link:https://sourceforge.net/projects/bowtie-bio/
It was a zipped file so I unzipped it.
I opened the unzipped folder on the terminal and then typed the command:
(base) linglabs-ipro:bowtie2-2.3.5.1-macos-x86_64 linglab$ bowtie2-build
-bash: bowtie2-build: command not found
(base) linglabs-ipro:bowtie2-2.3.5.1-macos-x86_64 linglab$
Please Help!
Comment
-
@sahil: Please go through this UNIX basics tutorial, if you are unfamiliar with the command line.
Comment
Latest Articles
Collapse
-
by SEQadmin2
Tumors contain complex mixtures of cell populations that evolve in response to treatment and host-specific factors. Tissue biopsies provide only static snapshots of a tumor’s state. But what if we could follow that evolution over time using a minimally invasive technique?
Liquid biopsies can detect tumor-derived material circulating in the bloodstream, providing a way to study treatment response, detect emerging resistance, and discover new biomarkers. Circulating...-
Channel: Articles
10-14-2026, 09:55 AM -
-
by SEQadmin2
Researchers using sequencing and genomics tools often have to make trade-offs. They can choose between speed or scale, short reads or long-range information, or targeted panels or a view of the whole transcriptome. New technologies that have been released this year are built to address those tough choices.
We asked six companies the same four questions to learn about their latest products. The new technologies bring a lot to the table, including rethinking sequencing...-
Channel: Articles
-
ad_right_rmr
Collapse
News
Collapse
| Topics | Statistics | Last Post | ||
|---|---|---|---|---|
|
Started by SEQadmin2, Yesterday, 11:13 AM
|
0 responses
16 views
0 reactions
|
Last Post
by SEQadmin2
Yesterday, 11:13 AM
|
||
|
Started by SEQadmin2, Yesterday, 10:48 AM
|
0 responses
17 views
0 reactions
|
Last Post
by SEQadmin2
Yesterday, 10:48 AM
|
||
|
Started by SEQadmin2, 10-15-2026, 10:52 AM
|
0 responses
35 views
0 reactions
|
Last Post
by SEQadmin2
10-15-2026, 10:52 AM
|
||
|
Started by SEQadmin2, 10-14-2026, 05:39 AM
|
0 responses
42 views
0 reactions
|
Last Post
by SEQadmin2
10-14-2026, 05:39 AM
|
Comment